✦ LIBER ✦

Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study

✍ Scribed by A.J. Cowley; K. Stainer; R.D. Wynne; J.M. Rowley; J.R. Hampton

Book ID: 119122562
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 540 KB
Volume: 24
Category: Article
ISSN: 0167-5273
DOI: 10.1016/0167-5273(89)90010-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-Blind Placebo-Controlled Comparis

Double-Blind Placebo-Controlled Comparison of Enoximone and Dobutamine Infusions in Patients With Moderate to Severe Chronic Heart Failure

✍ Feras M. Bader; Edward M. Gilbert; Neal A. Mehta; Michael R. Bristow 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 169 KB

Central and regional hemodynamic effects

Central and regional hemodynamic effects of oral enoximone in congestive heart failure: A double-blind, placebo-controlled study

✍ Carl V. Leier; John J. Lima; Steffen E.L. Meiler; Donald V. Unverfeth 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Peripheral hemodynamic effects of ibopam

Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study

✍ C. Longhini; L. Ansani; G. F. Musacci; S. Aggio; E. Baracca; T. Toselli; P. Ghir 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 282 KB

The effects of oral ibopamine in patient

The effects of oral ibopamine in patients with mild heart failure — a double blind placebo controlled comparison to furosemide

✍ John O Parker 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 801 KB

A comparison of the effects of captopril

A comparison of the effects of captopril and flosequinan in patients with severe heart failure

✍ A. J. Cowley; R. D. Wynne; A. Swami; J. Birkhead; A. Skene; J. R. Hampton 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 542 KB

Angiotensin converting enzyme inhibitors have greatly improved the treatment of patients with chronic heart failure but they are not effective in all patients, and their use may be limited by side effects. There is, therefore, a need to investigate new drugs and to compare their efficacy with angiot

A placebo-controlled, randomized, double

A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure

✍ Shigetake Sasayama 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 629 KB